UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

Science (American Association for the Advancement of Science), 2014-07, Vol.345 (6193), p.179-183

2014

Volltextzugriff (PDF)

Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy

Clinical infectious diseases, 2010-03, Vol.50 (6), p.912-919

2010

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals

Journal of Virology, 2009-03, Vol.83 (6), p.2715-2727

2009

Volltextzugriff (PDF)

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Proceedings of the National Academy of Sciences - PNAS, 2009-06, Vol.106 (23), p.9403-9408

2009

Volltextzugriff (PDF)

Antiretroviral Therapies in Women after Single-Dose Nevirapine Exposure

The New England journal of medicine, 2010-10, Vol.363 (16), p.1499-1509

2010

Volltextzugriff (PDF)

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

Annals of internal medicine, 1997-06, Vol.126 (12), p.946

1997

Volltextzugriff (PDF)

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

The New England journal of medicine, 1997-09, Vol.337 (11), p.734-739

1997

Volltextzugriff (PDF)

Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

Science (American Association for the Advancement of Science), 1996-05, Vol.272 (5265), p.1167-1170

1996

Volltextzugriff (PDF)

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel

JAMA : the journal of the American Medical Association, 2000-05, Vol.283 (18), p.2417

2000

Volltextzugriff (PDF)

A robust measure of HIV-1 population turnover within chronically infected individuals

Molecular biology and evolution, 2004-10, Vol.21 (10), p.1902-1912

2004

Volltextzugriff (PDF)

Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay

Journal of clinical virology, 2018-11, Vol.108, p.50-52

2018

Volltextzugriff (PDF)

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

Annals of internal medicine, 2000-07, Vol.133 (1), p.35

2000

Volltextzugriff (PDF)

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

JAMA : the journal of the American Medical Association, 1998-07, Vol.280 (1), p.35

1998

Volltextzugriff (PDF)

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Journal of Virology, 1996-12, Vol.70 (12), p.8270-8276

1996

Volltextzugriff (PDF)

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

Antimicrobial Agents and Chemotherapy, 1993-04, Vol.37 (4), p.875-881

1993

Volltextzugriff (PDF)

New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma

Journal of Clinical Microbiology, 2003-10, Vol.41 (10), p.4531-4536

2003

Volltextzugriff (PDF)

A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors

Antimicrobial Agents and Chemotherapy, 1997-12, Vol.41 (12), p.2781-2785

1997

Volltextzugriff (PDF)

In Vitro Selection of Mutations in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase That Decrease Susceptibility to (−)-β-d-Dioxolane-Guanosine and Suppress Resistance to 3′-Azido-3′-Deoxythymidine

Antimicrobial Agents and Chemotherapy, 2000-07, Vol.44 (7), p.1783-1788

2000

Volltextzugriff (PDF)

Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society-USA Panel

Clinical infectious diseases, 2003-07, Vol.37 (1), p.113-128

2003

Volltextzugriff (PDF)

Prolonged Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia in Persons with Advanced Disease Results in Enhancement of CD4 T Cell Reactivity to Microbial Antigens but Not to HIV-1 Antigens

The Journal of infectious diseases, 1999-02, Vol.179 (2), p.329-336

1999

Volltextzugriff (PDF)

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples

Advances in Virology, 2011-01, Vol.2011 (2011), p.1-12

2011

Volltextzugriff (PDF)

Natural History of Human Immunodeficiency Virus Type 1 Viremia after Seroconversion and Proximal to AIDS in a Large Cohort of Homosexual Men

The Journal of infectious diseases, 2000-03, Vol.181 (3), p.872-880

2000

Volltextzugriff (PDF)

Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates

Antimicrobial Agents and Chemotherapy, 1995-05, Vol.39 (5), p.1087-1092

1995

Volltextzugriff (PDF)

Prevalence of XMRV Nucleic Acid and Antibody in HIV-1-Infected Men and in Men at Risk for HIV-1 Infection

Advances in Virology, 2011-01, Vol.2011 (2011), p.1-6

2011

Volltextzugriff (PDF)

Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy

AIDS (London), 2006-03, Vol.20 (5), p.701-710

2006

Volltextzugriff (PDF)

1 – 25 von 440

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(417)
Mit Volltextzugriff
(347)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy

Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Antiretroviral Therapies in Women after Single-Dose Nevirapine Exposure

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel

A robust measure of HIV-1 population turnover within chronically infected individuals

Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma

A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors

In Vitro Selection of Mutations in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase That Decrease Susceptibility to (−)-β-d-Dioxolane-Guanosine and Suppress Resistance to 3′-Azido-3′-Deoxythymidine

Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society-USA Panel

Prolonged Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia in Persons with Advanced Disease Results in Enhancement of CD4 T Cell Reactivity to Microbial Antigens but Not to HIV-1 Antigens

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples

Natural History of Human Immunodeficiency Virus Type 1 Viremia after Seroconversion and Proximal to AIDS in a Large Cohort of Homosexual Men

Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates

Prevalence of XMRV Nucleic Acid and Antibody in HIV-1-Infected Men and in Men at Risk for HIV-1 Infection

Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy

Suchergebnisse filtern